You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HR genes

Showing 1 - 25 of 4,921
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

Completed
  • Epithelial Ovarian Cancer
  • +6 more
  • Evaluation of homologous recombination deficiency score
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Testing Circulating Tumour DNA for Homologous Recombination Gene

Recruiting
  • Circulating Tumor DNA
  • Metastatic Prostate Cancer
  • Blood sample
  • Urine sample
  • Tours, France
    University hospital
Sep 6, 2022

Esophageal Cancer, Gastric Cancer, Adenocarcinoma Trial in United States (Niraparib)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Tampa, Florida
  • +3 more
Jan 18, 2023

Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

Not yet recruiting
  • Melanoma
  • Fluzoparib Camrelizumab Temozolomide
  • (no location specified)
Aug 9, 2023

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Metastatic Melanoma Trial in San Francisco (Niraparib)

Recruiting
  • Metastatic Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Oct 15, 2021

Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

Recruiting
  • Breast Cancer
  • Capecitabine+endocrine therapy
  • Placebo+endocrine therapy
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 19, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Aug 4, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

HPV Integration on the Prognosis of Persistent HR-HPV Infection

Recruiting
  • HPV Infection
  • +3 more
  • Follow up
  • Fuzhou, Fujian, China
  • +10 more
Mar 7, 2022

Performance Determinants Factors in Elite Endurance Athletes.

Completed
  • Exercise Physiology
  • Age, Genes, Training, Tickbourne Disease and Endurance
  • Bø, Telemark, Norway
    Telemark University College
Aug 3, 2022

Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease Trial in Philadelphia (3H-cholesterol bound to albumin)

Suspended
  • Cholesterol, HDL
  • +4 more
  • 3H-cholesterol bound to albumin
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 14, 2022

Genetics, Metabolism, Type 2 Diabetes Trial in Boston (Mixed Meal Tolerance Test, Metformin)

Active, not recruiting
  • Genetics
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 4, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Smoking, Schizophrenia Trial in New Haven (Physostigmine)

Completed
  • Smoking
  • Schizophrenia
  • New Haven, Connecticut
  • +2 more
Oct 24, 2022

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

Completed
  • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
  • Avelumab Phase 1b
  • +3 more
  • Fayetteville, Arkansas
  • +57 more
Jan 18, 2023

Metastatic Melanoma Trial in San Francisco (Olaparib, Pembrolizumab)

Recruiting
  • Metastatic Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Apr 30, 2021

Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

Recruiting
  • Urothelial Cancer
  • Niraparib plus Cabozantinib
  • Barcelona, Cataluña, Spain
  • +10 more
Feb 8, 2022

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Acute Kidney Injury Trial in Houston (Pantoprazole, Famotidine)

Not yet recruiting
  • Acute Kidney Injury
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Nov 29, 2023

Response With lIquid BiopsY evaLuation

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Guardant360
  • (no location specified)
Jun 29, 2023

Breast Cancer Trial in Spain (Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Sep 3, 2021

Breast Cancer Metastatic Trial in Sweden, United Kingdom (Palbociclib, Fulvestrant, Capecitabine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Göteborg, Sweden
  • +8 more
Mar 29, 2022